to clarify that the amount received by the dispensing pharmacy or other dispensing provider, and not the amount paid by the Part D sponsor to the PBM, is the basis for determining the drug costs that must be reported to CMS. CMS also clarified that when a beneficiary is responsible for 100% of the cost for a covered Part D drug and obtains that drug at a network pharmacy for a price below the plan